Editorial Board

Alex C. Spyropoulos, MD, FACP, FCCP

Alex C. Spyropoulos, MD received his medical degree from the University of Pennsylvania School of Medicine in Philadelphia. He completed his internship and residency in internal medicine at the University of New Mexico Health Sciences Center in Albuquerque, NM. He is board certified in internal medicine.

Dr. Spyropoulos is Founder and current Medical Director of the Clinical Thrombosis Center at Lovelace Health Systems in Albuquerque, New Mexico. As Clinical Associate Professor of Medicine and Associate Professor of Pharmacy at the University of New Mexico Health Sciences Center, he has developed a clinical thrombosis curriculum as part of the ambulatory medicine rotation. He is a Fellow of the American College of Physicians and American College of Chest Physicians.

As a disease management consultant on anticoagulation in a managed care setting, Dr. Spyropoulos has been an integral member of Lovelace's Episode of Care disease management program on anticoagulation. He has helped to develop protocols using LMWH in outpatient-based treatment of venous thromboembolic disease, perioperative "bridging" for patients on chronic anticoagulation, post-operative DVT and medical inpatient prophylaxis, and protocols with regards to the use of lepirudin for HIT. Dr. Spyropoulos is active in assessing outcome analyses of these protocols, especially with regards to the implementation, safety, efficacy, and pharmacoeconomic indicators, and has lectured extensively both nationally and internationally on these issues.

Dr. Spyropoulos clinical and outcomes research interests include the use of once-daily LMWH for treatment of venous thromboembolic disease, the use of LMWH in the treatment of pulmonary embolism, especially in the outpatient setting, the use of LMWH in special patient populations such as malignancy and pregnancy, pharmacoeconomic evaluation of outpatient DVT treatment programs, and perioperative "bridging" outcomes using LMWH. His interests also include QOL and other outcomes measures in the anticoagulation clinic, such as the use of patient self-testing devices for chronic anticoagulation. He is the Principal Investigator of a national registry for patients on chronic oral anticoagulant therapy needing "bridge" therapy, is a member of the Steering Committee for IMPROVE, an international registry on VTE prophylaxis among medical patients, and a Steering Committee member of a multicenter bridging clinical study. He is a panel member of a national experts consensus group for clinical excellence in thrombosis management, a Steering Committee member of an international expert's panel in medical thromboprophylaxis, a faculty member of the 2004 International Consensus Statement on Prevention of VTE, and a member of the Anticoagulation Forum. He is a reviewer for many journalsCHEST, Circulation, and Journal of Thrombosis and Thrombolysis.

Dr. Spyropoulos' articles, letters, and editorials have been published in numerous journals and newsletters such as Archives of Internal Medicine, Annals of Internal Medicine, Chest, Cardiovascular Reviews and Reports, Pharmacotherapy, Journal of Clinical Rheumatology, Journal of Managed Care Pharmacy, Journal of Thrombosis and Thrombolysis, Canadian Journal of Family Practice, and American Journal of Managed Care.

Dr. Spyropoulos receives research grants from Sanofi-Aventis and works as a consultant for Sanofi-Aventis, AstraZeneca, and Boeringer-Ingelheim.

Editorial Board Members

• Henry I. Bussey, Pharm.D., FCCP, FAHA -- San Antonio, TX
• Marie B. Walker, BBA -- Fresno, CA & San Antonio, TX
• Mary Amato, Pharm.D., MPH -- Boston, MA
• Jack E. Ansell, M.D. -- Boston, MA
• William E. Dager, Pharm.D., FCSHP -- Sacramento, CA
• Susan C. Fagan, Pharm.D., BCPS, FCCP -- Augusta, GA
• Samuel Z. Goldhaber, M.D. -- Boston, MA
• James B. Groce III, Pharm.D., CACP -- Greensboro, NC
• Stuart T. Haines, Pharm.D., FCCP, FASHP, FAPhA -- W. Palm Beach, FL
• David W. Hawkins, Pharm.D. -- Sacramento, CA
• Elaine M. Hylek, MD, MPH -- Boston, MA
• Roger M. Lyons, MD, FACP -- San Antonio, TX
• Ruth Morrison, R.N., B.S.N., C.V.N. -- Boston, MA
• Edith A. Nutescu, Pharm.D. -- Chicago, IL
• Sarah A. Spinler, PharmD, FCCP, BCPS (AQ Cardiology) -- Philadelphia, PA
• Alex C. Spyropoulos, MD, FACP, FCCP -- Albuquerque, NM
• Victor F. Tapson, M.D. -- Durham, NC
• Alexander G.G. Turpie, MD, FRCP, FACP, FACC, FRCPC -- Hamilton, Ontario, Canada
• Robert T. Weibert, Pharm.D. -- San Diego, CA
• Ann K Wittkowsky, PharmD, CACP, FASHP, FCCP -- Seattle, WA